Viewing Study NCT05353192


Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2025-12-26 @ 1:51 PM
Study NCT ID: NCT05353192
Status: UNKNOWN
Last Update Posted: 2023-02-28
First Post: 2022-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GenSci001-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View
None OTHER View
None OTHER View